Role of saffron and its constituents on cancer chemoprevention

Pharmaceutical Biology

Volumn 51, Issue 7, 2013, Pages 920-924

  Zhang, Zhiyu ^a,b   Wang, Chong Zhi ^a,b   Wen, Xiao Dong ^a,b   Shoyama, Yukihiro ^c   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Anticancer; Chemoprevention; Crocin; Crocus sativus; Cytotoxicity; Dietary supplements; Saffron

Indexed keywords

CROCIN; CROCUS SATIVUS EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER PREVENTION; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL CARCINOMA; CROCUS SATIVUS; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; FLOWER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LUNG CANCER; LYMPHOMA; NONHUMAN; OUTCOMES RESEARCH; PANCREAS CANCER; PHYTOCHEMISTRY; REVIEW; SOFT TISSUE SARCOMA; SOLID TUMOR; SURVIVAL TIME;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CROCUS; FREE RADICAL SCAVENGERS; HUMANS; MEDICINE, TRADITIONAL; NEOPLASMS; PLANT EXTRACTS; QUALITY OF LIFE;

CROCUS SATIVUS; IRIDACEAE;

EID: 84879327936     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.771190     Document Type: Review

References (62)

1. Abdullaev FI, Frenkel GD. (1992). Effect of saffron on cell colony formation and cellular nucleic acid and protein synthesis. Biofactors 3:201-04
2. Abdullaev FI. (1994). Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett 70:243-51
3. Abdullaev FI. (2001). Plant-derived agents against cancer. In: Gupta SK, ed. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House, 345-54
4. Abdullaev FI. (2003). Crocus sativus against cancer. Arch Med Res 34:354-63
5. Abdullaev FI, Espinosa-Aguirre JJ. (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 28:426-32 (Pubitemid 39568938)
6. Amin A, Hamza AA, Bajbouj K, et al. (2011). Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54:857-67
7. Attele AS, Wu JA, Yuan CS. (1999). Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58:1685-93 (Pubitemid 29505408)
8. Aung HH, Wang CZ, Ni M, et al. (2007). Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 29:175-80 (Pubitemid 350206742)
9. Bakshi HA, Sam S, Feroz A, et al. (2009). Crocin from Kashmiri saffron (Crocus sativus) induces in vitro and in vivo xenograft growth inhibition of Dalton's lymphoma (DLA) in mice. Asian Pac J Cancer Prev 10:887-90
10. Bakshi H, Sam S, Rozati R, et al. (2010). DNA fragmentation and cell cycle arrest: A hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev 11:675-9
11. Bors W, Saran M, Michel C. (1982). Radical intermediates involved in the bleaching of the carotenoid crocin. Hydroxyl radicals, superoxide anions and hydrated electrons. Int J Radiat Biol Relat Stud Phys Chem Med 41:493-501 (Pubitemid 12115113)
12. Chryssanthi DG, Lamari FN, Iatrou G, et al. (2007). Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res 27:357-62 (Pubitemid 46363354)
13. Dhar A, Mehta S, Dhar G, et al. (2009). Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther 8:315-23
14. Dufresne C, Cormier F, Dorion S. (1997). In vitro formation of crocetin glucosyl esters by Crocus sativus callus extract. Planta Med 63:150-3 (Pubitemid 27196084)
15. El-Daly ES. (1998). Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg 53:93-5
16. Erben-Russ M, Michel C, Bors W, et al. (1987). The reaction of sulfite radical anion with nucleic acid components. Free Radic Res Commun 2:289-94
17. Escribano J, Piqueras A, Medina J, et al. (1999). Production of a cytotoxic proteoglycan using callus culture of saffron corms (Crocus sativus L.). J Biotechnol 73:53-9 (Pubitemid 29347189)
18. Feizzadeh B, Afshari JT, Rakhshandeh H, et al. (2008). Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urol J 5:161-7
19. García-Olmo DC, Riese HH, Escribano J, et al. (1999). Effects of longterm treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): An experimental study in the rat. Nutr Cancer 35:120-6 (Pubitemid 30115121)
20. Garodia P, Ichikawa H, Malani N, et al. (2007). From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 5:25-37 (Pubitemid 46648393)
21. Giaccio M. (2004). Crocetin from saffron: An active component of an ancient spice. Crit Rev Food Sci Nutr 44:155-72 (Pubitemid 38732378)
22. Hemaiswarya S, Doble M. (2006). Potential synergism of natural products in the treatment of cancer. Phytother Res 20:239-49
23. Hwang JW, Oh JH, Yoo HS, et al. (2012). Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-B. Am J Chin Med 40:187-202
24. Johnson TE, Hermanson D, Wang L, et al. (2011). Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice. Am J Chin Med 39:727-42
25. Kim SH, Huang CY, Tsai CY, et al. (2012). The aqueous extract of Prunella vulgaris suppresses cell invasion and migration in human liver cancer cells by attenuating matrix metalloproteinases. Am J Chin Med 40:643-56
26. Lai ZR, Ho YL, Huang SC, et al. (2011). Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem. Am J Chin Med 39:1275-90
27. Lechtenberg M, Schepmann D, Niehues M, et al. (2008). Quality and functionality of saffron: Quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and sigma1 (sigma-1) receptors. Planta Med 74:764-72 (Pubitemid 351881002)
28. Lee BM, Park KK. (2003). Beneficial and adverse effects of chemopreventive agents. Mutat Res 523-524:265-78 (Pubitemid 36293253)
29. Li CY, Wu TS. (2002). Constituents of the stigmas of Crocus sativus and their tyrosine inhibitory activity. J Nat Prod 65:1452-6
30. Li CY, Lee EJ, Wu TS. (2004). Antitirosine principles and constituents of the petals of Crocus sativus. J Nat Prod 67:437-40
31. Lin CM, Chen YH, Ong JR, et al. (2012). Functional role of wogonin in anti-Angiogenesis. Am J Chin Med 40:415-27
32. Magesh V, Singh JP, Selvendiran K, et al. (2006). Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem 287:127-35 (Pubitemid 44057400)
33. Martin G, Goh E, Neff AW. (2002). Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem Toxicol 40:959-64 (Pubitemid 34626704)
34. Morjani H, Tarantilis P, Polissiou M, et al. (1990). Growth inhibition and induction of crythroid differentiation activity by crocin, dimethylcrocetine and b-carotene on K562 tumor cells. Anticancer Res 10:1398-406
35. Mousavi SH, Tavakkol-Afshari J, Brook A, et al. (2009). Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol 47:1909-13
36. Nair SC, Panikkar B, Panikkar KR. (1991). Antitumor activity of saffron (Crocus sativus). Cancer Lett 57:109-14
37. Nair SC, Salomi MJ, Varghese CD, et al. (1992). Effect of saffron on thymocute proliferation, intracellular gluthation levels and its antitumor activity. BioFactors 4:51-4 (Pubitemid 23032886)
38. Nair SC, Panikkar KR, Parathod RK. (1993). Protective effects of crocetin on bladder cytotoxicity induced by cyclophosphamide. Cancer Biother 8:339-43 (Pubitemid 2018627)
39. Nair SC, Varghese CD, Pannikar KR, et al. (1994). Effects of saffron in vitamin A levels and its antitumor activity on the growth of solid tumors in mice. Int J Pharmacog 32:105-14 (Pubitemid 24220632)
40. Nair SC, Kurumboor SK, Hasegawa JH. (1995). Saffron chemoprevention in biology and medicine: A review. Cancer Biother 10:257-64
41. Premkumar K, Abraham SK, Santhiya ST, et al. (2001). Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug Chem Toxicol 24:421-8 (Pubitemid 32959248)
42. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. (2003). Protective effects of saffron (Crocus sativus L.) on genotoxin-induced oxidative stress in Swiss mice. Phytother Res 17:614-17 (Pubitemid 36781735)
43. Premkumar K, Thirunavukkarasu C, Abraham SK, et al. (2006). Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-Tumor agents in mice. Hum Exp Toxicol 25:79-84 (Pubitemid 43345342)
44. Randhawa MA, Alghamdi MS. (2011). Anticancer activity of Nigella sativa (black seed)-A review. Am J Chin Med 39:1075-91
45. Salomi MJ, Nair SC, Panikkar KR. (1991). Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer 16:67-72
46. Schmidt M, Betti G, Hensel A. (2007). Saffron in phytotherapy: Pharmacology and clinical uses. Wien Med Wochenschr 157:315-19 (Pubitemid 47356256)
47. Shen KH, Chen ZT, Duh PD. (2012). Cytotoxic effect of Eucalyptus citriodora resin on human hepatoma HepG2 cells. Am J Chin Med 40:399-413
48. Smith TA. (1998). Carotenoids and cancer: Prevention and potential therapy. Br J Biomed Sci 55:268-75 (Pubitemid 29050639)
49. Tarantilis PA, Morjani HM, Polissiou M, et al. (1994). Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res 14:1913-18
50. Tarantilis PA, Polissiou M. (1997). Isolation and identification of the aroma constituents of saffron (Crocus sativa). J Agri Food Chem 45:459-62 (Pubitemid 127485951)
51. Tseng TH, Chu CY, Huang JM, et al. (1995). Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett 97:61-7
52. Venook A. (2005). Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 10:250-61 (Pubitemid 40559590)
53. Wang CZ, Calway T, Yuan CS. (2012). Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 40:657-69
54. Wintherhalter P, Straubinger M. (2000). Saffron-Renewed interest in an ancient spice. Food Rev Int 16:39-59
55. Wu G, Qian Z, Guo J, et al. (2012). Ganoderma lucidum extract induces g1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med 40:631-42
56. Xu Z, Chen X, Zhong Z, et al. (2011). Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-Tumor activities. Am J Chin Med 39:15-27
57. Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, et al. (2011). A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. Oncologist 16:1197-202
58. Yamaguchi Y, Miyahara E, Hihara J. (2011). Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: A pilot study. Am J Chin Med 39:451-9
59. Yang SW, Wang W, Xie XY, et al. (2011). In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells. Am J Chin Med 39:121-34
60. Yun TK, Zheng S, Choi SY, et al. (2010). Non-organ-specific preventive effect of long-Term administration of Korean red ginseng extract on incidence of human cancers. J Med Food 13:489-94
61. Zakaria ZA, Mohamed AM, Jamil NS, et al. (2011). In vitro antiproliferative and antioxidant activities of the extracts of Muntingia calabura leaves. Am J Chin Med 39:183-200
62. Zareena AV, Variar PS, Gholar AS, et al. (2001). Chemical investigation of gamma-irradiated saffron (Crocus sativus L.). J Agric Food Chem 49:687-91 (Pubitemid 32172613)